Aplix AAQS
The The AAQS of Aplix (3727.T) as of Nov 2, 2026 is 3. In the previous year, The AAQS was 3.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
3
YoY
0.00%
Last updated:
Aplix has a current AAQS of 3.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Aplix in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Aplix in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Aplix AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2018
3.00 JPY
Jan 1, 2019
3.00 JPY
Jan 1, 2020
3.00 JPY
Jan 1, 2021
3.00 JPY
Jan 1, 2022
3.00 JPY
Jan 1, 2023
3.00 JPY
Jan 1, 2024
3.00 JPY
Jan 1, 2025
3.00 JPY
| YEAR | AAQS | YoY |
|---|---|---|
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Aplix Stock analysis
What does Aplix do? Aplix Corp is a leading developer and manufacturer of innovative technology solutions. The company is based in Japan and was originally founded in 1986 as a software development company. Since then, it has evolved into an internationally active company specializing in the development of software, hardware, and other electronics products.
One of the company's main divisions is the development of software systems and applications. Aplix utilizes a wide range of operating systems and technologies, including Windows, Linux, Android, and iOS. The company is known for its cross-platform development and distribution solutions, as well as its mobile computer software that runs on a variety of mobile devices.
In addition to software systems, the company also offers hardware products, including digital cameras and other electronic devices. These devices are used in a variety of applications, from leisure and sports photography to surveillance and security. Aplix has also developed defined industry solutions, such as medical devices and transportation technology.
Another important area of Aplix is the development and manufacturing of textiles and other accessories for the fashion industry. The company utilizes versatile technologies and products to develop innovative solutions in this field. For example, the company has developed the use of "smart fabrics" that are equipped with embedded and wireless sensors and are wearable. These products, for instance, serve as fitness and health trackers.
Aplix has also focused on providing solutions for the healthcare industry. The company has developed a wide range of products that help improve medical care by facilitating the diagnosis and treatment of diseases. For example, Aplix has developed wearable devices that can monitor blood pressure and heart rate. There are also ongoing projects in the development of telemedicine applications.
In recent times, the company has built strong collaborations in the field of artificial intelligence to leverage the technology in supporting high-tech platforms and applications. The company plans to integrate these technologies into various areas within the company to develop innovative solutions.
Overall, Aplix has established itself as an innovative company specializing in diverse industries and requirements. Since its founding, the company has built footholds in various areas and has filed a significant number of patents over the years. All of these have contributed to the company's strong presence in software development, hardware, and critical-textile business today. Aplix is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Aplix stock
The AAQS of Aplix is 3 in 2025.
On Eulerpool you can find the complete historical development of The AAQS Aplix since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Aplix
All Key Metrics — Aplix
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth